CSIQ enters the week having shed 12% in five sessions, with the borrow market tightening sharply and short interest running at one of the highest levels in the Nasdaq solar cohort — a combination that has rarely been comfortable for longs.
The positioning story is the most instructive thing about this stock right now. Short interest has held firm at 22.5% of free float — a level that ranks in the 2nd percentile of the entire ORTEX universe on the short-score scale, meaning almost every other tracked stock carries less bearish structural overhang. What makes this week different is the acceleration in borrow tightness: availability dropped to 28.1%, down sharply from 43% two weeks ago and approaching the tightest levels seen over the past year (the 52-week low hit 7.7%). Cost to borrow has climbed alongside it, up 10% on the week to just under 2%. That is still a modest absolute rate, so new shorts remain easy to initiate — but the rapid direction of travel in availability suggests demand for borrows is rising into the price decline, not receding. Options positioning offers no counterweight: the put/call ratio at 0.28 is pinned near its 52-week low of 0.19, meaning the options market is not pricing in meaningful downside protection. Calls are running roughly 3.5x puts. That divergence — shorts very committed, options buyers mostly bullish — is the central tension.
The Street picture is muted at best. Mizuho lifted its target to $18 from $15 last week, maintaining a Neutral rating, which feels like a grudging acknowledgement of undervaluation rather than conviction. The mean target across analysts sits at $17.46, implying roughly 19% upside from the $14.73 close — but the direction of recent revisions tells a more cautious story. Wells Fargo trimmed to $17 from $23 in April; Roth Capital cut to $15 from $30 in March; Oppenheimer slashed to $19 from $38 in the same month. Every major revision in 2026 before the most recent Mizuho move was a cut, some of them severe. The ORTEX short score has climbed steadily to 74.8, near a rolling 10-day high, which ranks CSIQ in the bottom 2% of all stocks on short-score pressure. Factor scores add nuance: 30-day EPS momentum sits in the 98th percentile — a bright spot — but quality ranks just in the 9th percentile on utilization-rank and the 4th percentile on days-to-cover, reflecting how stretched the bearish positioning has become relative to average daily volume.
The valuation floor is real but not obviously a catalyst on its own. Price-to-book has compressed to 0.32 — deeply distressed territory — while EV/EBITDA at 9.6x has contracted by roughly half a point over the past month as the stock fell faster than earnings estimates. The earnings yield is negative, flagging that current reported earnings are a headwind. The bull case rests on that value floor and the 30-day EPS momentum surge; the bear case rests on structurally negative returns on capital, a low Piotroski F-score, and the weight of 22% short interest that has been slowly but steadily declining from its May peak near 26% — meaning some covering has occurred, yet conviction among remaining shorts appears undimmed.
The broader solar peer group offered no refuge this week. JKS fell 13% on the week, nearly matching CSIQ's decline, while FSLR lost almost 9%. The selling is clearly sector-wide rather than CSIQ-specific. That context matters: a purely stock-specific catalyst has not been the driver of the recent leg lower, which makes the elevated short interest harder to read as informed versus macro-driven.
The next scheduled earnings release is August 14. Whether the tightening borrow pool and the gap between the options market's call-heavy positioning and the short sellers' conviction begins to close — or widens further into that print — is the key dynamic to track over the next six weeks.
See the live data behind this article on ORTEX.
Open CSIQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.